Live Breaking News & Updates on Bruno Sepodes

Stay updated with breaking news from Bruno sepodes. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

EU regulator authorizes AstraZeneca vaccine for all adults | News, Sports, Jobs


EU regulator authorizes AstraZeneca vaccine for all adults
By Staff | Jan 30, 2021
FILE - In this Jan. 2, 2021 file photo a vial of the COVID-19 vaccine developed by Oxford University and U.K.-based drugmaker AstraZeneca is checked as they arrive at the Princess Royal Hospital in Haywards Heath, England. The European Medicines Agency is expected on Friday Jan. 29, 2021 to authorize use of the vaccine AstraZeneca developed with Oxford University. It would be the third cleared for use in the EU, after the BioNTech-Pfizer and Moderna vaccines. (Gareth Fuller/Pool via AP, File)
BERLIN (AP) Regulators authorized AstraZeneca’s coronavirus vaccine for use in adults throughout the European Union on Friday, amid criticism the bloc is not moving fast enough to vaccinate its population. ....

United Kingdom , South Africa , Bruno Sepodes , Zivile Simonaityte , Thomas Mertens , Emer Cooke , Julian Tang , University Of Leicester , Eu Commission , World Health Organization , European Commission , Baltic News Service , European Medicines Agency , European Union On , European Union , President Ursula , Health Minister Zivile Simonaityte , Baltic News , Covid 19 , Eu Regulator Authorizes Astrazeneca Vaccine For All Adults , ஒன்றுபட்டது கிஂக்டம் , தாமஸ் மேர்தேன்ஸ் , எமர் சமைக்க , ஜூலியன் டாங் , பல்கலைக்கழகம் ஆஃப் லெய்செஸ்டர் , யூ தரகு ,

UPDATE 3-European regulator gives green light for Astra-Oxford COVID-19 vaccine


Ludwig Burger, Pushkala Aripaka
(Adds comments from news conference, reaction)
Jan 29 (Reuters) - Europe’s medicines regulator on Friday approved AstraZeneca and Oxford University’s COVID-19 vaccine for people over the age of 18, the third vaccine to be cleared for use in the European Union.
The AstraZeneca vaccine demonstrated an efficacy of around 60% in the trials on which the decision was based, the European Medicines Agency (EMA) said in a statement bit.ly/3pwGYlx.
That is well below the level of protection shown by authorised vaccines from Pfizer and its German partner BioNTech and rival Moderna, which were around 95% effective in preventing symptomatic illness in pivotal trials. ....

Bruno Sepodes , Ludwig Burger , Elaine Hardcastle , Emer Cooke , Douglas Busvine , Pascal Soriot , Emilio Parodi , Antonella Viola , Pushkala Aripaka , Kirsten Donovan , European Union , European Medicines Agency , University Of Padua , Oxford University , Executive Director , Milan Writing , Keith Weir Editing , லுட்விக் பர்கர் , எலைன் ஹார்ட் கேஸில் , எமர் சமைக்க , எமீலியோ பரோடி , அன்டோனெல்லா வயல , கர்ஸ்டந் டொநொவந் , ஐரோப்பிய தொழிற்சங்கம் , பல்கலைக்கழகம் ஆஃப் ப்யாட்யூவ , ஆக்ஸ்ஃபர்ட் பல்கலைக்கழகம் ,